Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07598461

Splintless Versus Conventional Maxillomandibular Advancement Surgery for Obstructive Sleep Apnea

The goal of this clinical trial is to find out whether using a splintless surgical approach improves the accuracy of maxillomandibular advancement (MMA) surgery for treating obstructive sleep apnea (OSA) in adults. The study will also look at the safety, functional outcomes, and cost-effectiveness of the splintless approach. The main questions it aims to answer are:

Does the splintless approach lead to more accurate surgical movements of the jaws compared to the conventional splint-based method? What are the safety profile, functional outcomes, and cost-effectiveness of the splintless approach?

Researchers will compare splintless MMA to conventional MMA.

Patients will:

Undergo MMA surgery using either the splintless or splint-based method; Attend regular follow-up visits as part of routine care; Complete questionnaires and undergo assessments at various time points; Receive one additional CT scan (24 months after surgery) and one overnight sleep study (60 months after surgery).

Bedpartners of patients will:

Complete questionnaires at various time points.

This trial will help determine whether the splintless approach is a better, safer, and more effective alternative for treating OSA with MMA surgery.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Oral and Maxillofacial Surgery, Amsterdam UMC

Amsterdam, North Holland, 1105 AZ, Netherlands

Location contact

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

For OSA patients:

  • Adults aged 18 years or older;
  • Moderate to severe OSA (apnea hypopnea index (AHI) ≥ 15 events/hour) as determined by an overnight polysomnography (PSG) preoperatively;
  • Continunous positive airway pressure failure or intolerance;
  • General good health for surgery;
  • MMA surgery indicated for OSA treatment.

For bedpartners of patients:

  • Sharing a bed ⩾2 nights/week with patient.

Exclusion criteria

For OSA patients:

  • Other adjunctive procedures indicated at the time of MMA (e.g., multi-piece Le Fort I osteotomy, temporomandibular joint reconstruction);
  • Previous history of orthognathic surgery;
  • Cleft palate and syndromic patients;
  • Refusal to participate.

For bedpartners of patients:

  • Refusal to participate.

Treatment and study plan

Splintless MMA surgery

Procedure

Splintless orthognathic surgery is a more recent technical innovation in Oral and Maxillofacial surgery, in which patient-specific computer-aided design and manufacturing (CAD/CAM) surgical cutting guides and fixation implants are used to improve surgical precision. Splintless MMA sugery involves virtual surgical planning, surgical procedures, and postoperative monitoring.

Splint MMA surgery

Procedure

In splint MMA surgery, surgical procedure is virtually planned in three dimensions (3D) and the surgical planning is transfered to the operating room with 3D-printed intermediate and final splints. These splints are used during surgery to place and fixate the maxilla and mandible in the planned position.

Primary outcomes

  1. Surgical accuracy

    Time frame: 1 week after MMA

    Because the main objective of MMA for OSA is achieving the planned advancement and counter-clockwise rotation to relieve the upper airway collapse, anteroposterior translation of the maxilla and mandible, and pitch of the maxilla and mandible are the main study parameters.

    The postoperative CT scan is superimposed on the preoperative virtual planning. The absolute difference between the planned value for a parameter and the postoperative acquired value will be calculated, which provides an intuitive accuracy measurement of MMA surgery.

Secondary outcomes

  1. Other translational surgical movement parameters

    Time frame: 1 week after MMA

    Mediolateral and superoinferior movement of the maxilla and mandible in millimeters measured by CT scan

  2. Other rotational surgical movement parameters

    Time frame: 1 week after MMA

    Roll and yaw of the maxilla and mandible in degrees measured by CT scan

  3. Duration of surgery

    Time frame: During MMA surgery

    The time between the start of incision and the suture of the incisions.

  4. Blood loss

    Time frame: During MMA surgery

    Blood loss during surgery

  5. Adverse events/complications

    Time frame: During MMA surgery and follow-Ups (up to 60 months postoperatively)

    Intra- and post-operative adverse events/complications

  6. Apnea hypopnea index

    Time frame: Preoperatively, six months postoperatively, and 60 months postoperatively

    The average number of apnea and hypopnea events per hour of sleep during a sleep study (polysomnography)

  7. 3% oxygen desaturation index

    Time frame: Preoperatively, six months postoperatively, and 60 months postoperatively

    Number of times per hour of sleep that blood oxygen saturation drops by ≥3% from baseline during a sleep study

  8. Lowest oxygen saturation

    Time frame: Preoperatively, six months postoperatively, and 60 months postoperatively

    The minimum blood oxygen level (%) reached during a sleep study

  9. Percentage of sleep time spent with oxygen saturation < 90%

    Time frame: Preoperatively, six months postoperatively, and 60 months postoperatively

    Percentage of sleep time spent with blood oxygen saturation < 90% during a sleep study

  10. Epworth sleep scale (ESS) total score

    Time frame: Preoperatively, and 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, and 60 months after MMA

    Daytime sleepiness as assessed with Epworth sleep scale total score (range 0-24; higher scores indicate greater daytime sleepiness / worse outcome)

  11. Functional Outcomes of Sleep Questionnaire (FOSQ) total score

    Time frame: Preoperatively, and 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, and 60 months after MMA

    Functional status as assessed with Functional Outcomes of Sleep Questionnaire total score (range 5-20; higher scores indicate better functional status / less impairment due to sleepiness)

  12. Pittsburgh Sleep Quality Index (PSQI) global score

    Time frame: Preoperatively, and 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, and 60 months after MMA

    Sleep quality as assessed with Pittsburgh Sleep Quality Index global score (range 0-21; higher scores indicate worse sleep quality)

  13. EuroQol 5-Dimension 5-Level (EQ-5D-5L) utility index

    Time frame: Preoperatively, and 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, and 60 months after MMA

    Patient's health status as assessed with EuroQol 5-Dimension 5-Level utility index (utility index ranges from <0 to 1; higher scores indicate better health-related quality of life)

  14. EuroQol 5-Dimension 5-Level (EQ-5D-5L) visual analogue scale (VAS) score

    Time frame: Preoperatively, and 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, and 60 months after MMA

    Patient's health status as assessed with EuroQol 5-Dimension 5-Level visual analogue scale (VAS) score (VAS ranges 0-100, higher scores indicate better health status)

  15. 36-Item Short Form Health Survey (SF-36) domain and summary scores

    Time frame: Preoperatively, and 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, and 60 months after MMA

    Quality of life as assessed with 36-Item Short Form Health Survey domain and summary scores (range 0-100; higher scores indicate better health-related quality of life)

  16. FACE-Q satisfaction with facial appearance score

    Time frame: Preoperatively, and 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, and 60 months after MMA

    Patient satisfaction with facial appearance as assessed using the FACE-Q questionnaire (range 0-100; higher scores indicate greater satisfaction with facial appearance / better outcome)

  17. Patient satisfaction with facial appearance and surgical outcome

    Time frame: Preoperatively, and 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, and 60 months after MMA

    Patient's satisfaction with surgery outcomes as assessed with customized patient satisfaction questionnaire (5-point Likert scales; higher ratings indicate greater satisfaction)

  18. Partner-reported snoring severity, snoring disturbance, and satisfaction with postoperative facial appearance (5- to 6-point Likert scales)

    Time frame: Preoperatively and 6 months after MMA

    Partner-reported assessment of snoring severity, snoring-related disturbance, and perceived postoperative facial appearance changes using a study-specific questionnaire completed by the participant's partner (higher ratings indicate greater snoring severity/disturbance or more positive perceived facial change, depending on the item).

  19. Postsurgical relapse measures

    Time frame: 2 years after MMA

    Postsurgical relapse measures in translation parameters (anteroposterior, mediolateral, superoinferior) and rotation parameters (roll, pitch, yaw) of the maxilla and mandible. The discrepancy between immediately post-operation (1 week after MMA) and 2 years after surgery will be used to define the amount of relapse.

  20. Facial soft tissue changes

    Time frame: 6 months after MMA

    Facial soft tissue changes following MMA at various soft-tissue points. These are determined by the difference in 3D coordinates of soft tissue landmarks between baseline and 6 months after MMA;

  21. Upper airway volume

    Time frame: Preoperatively and 6 months after MMA

    Upper airway volume (mm³) measured using three-dimensional imaging analysis

  22. Upper airway length

    Time frame: Preoperatively and 6 months after MMA

    Upper airway length measured using three-dimensional imaging analysis (mm)

  23. Upper airway surface area

    Time frame: Preoperatively and 6 months after MMA

    Upper airway surface area (mm²) measured using three-dimensional imaging analysis

  24. Upper airway minimum cross-sectional area (minCSA)

    Time frame: Preoperatively and 6 months after MMA

    Minimum cross-sectional area (mm²) of the upper airway measured using three-dimensional imaging analysis

  25. Lateral dimension of the minimum cross-sectional area of the upper airway

    Time frame: Preoperatively and 6 months after MMA

    Lateral dimension of the upper airway minimum cross-sectional area (mm) measured using three-dimensional imaging analysis.

  26. Anteroposterior dimension of the minimum cross-sectional area of the upper airway

    Time frame: Preoperatively and 6 months after MMA

    Anteroposterior dimension of the upper airway minimum cross-sectional area (mm) measured using three-dimensional imaging analysis.

  27. Blood pressure

    Time frame: Preoperatively, and 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, and 60 months after MMA

    Systolic and diastolic blood pressure

  28. Cost-effectiveness

    Time frame: 6, 12, 24, 36, 48, and 60 months after MMA

    Incremental cost-effectiveness ratio (ICER) and incremental cost-utility ratio (ICUR).

Study contacts

Contact information is provided by the study sponsor or research team.

Sponsors and collaborators

Lead sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Other

Collaborators

  • Materialise

Registry information

Official study title

Splintless Versus Conventional Maxillomandibular Advancement Surgery for Obstructive Sleep Apnea: a Randomized Controlled Trial

Acronym: SvCMAS

Important dates

Study start
2026
Primary completion
2028
Study completion
2033
First posted
May 20, 2026
Registry last updated
May 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.